|
C3ORF10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.787000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.595600E-01 |
| Normal-vs-Stage2 |
7.443000E-01 |
| Normal-vs-Stage3 |
4.811600E-01 |
| Normal-vs-Stage4 |
2.172100E-02 |
| Stage1-vs-Stage2 |
8.111000E-01 |
| Stage1-vs-Stage3 |
5.571200E-01 |
| Stage1-vs-Stage4 |
2.168200E-02 |
| Stage2-vs-Stage3 |
8.632600E-01 |
| Stage2-vs-Stage4 |
1.697360E-01 |
| Stage3-vs-Stage4 |
1.357790E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.720000E-01 |
| Normal-vs-AfricanAmerican |
5.275200E-01 |
| Normal-vs-Asian |
5.379200E-01 |
| Caucasian-vs-AfricanAmerican |
2.839600E-01 |
| Caucasian-vs-Asian |
8.958600E-01 |
| AfricanAmerican-vs-Asian |
3.036200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.006400E-01 |
| Normal-vs-Female |
6.484000E-01 |
| Male-vs-Female |
4.554200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.976600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.948200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.884200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.762800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.939600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.408600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.438200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.882600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.434400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.961600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.690200E-02 |
| Classical-VS-Follicular |
7.376600E-01 |
| Classical-VS-Other |
6.904400E-01 |
| Classical-VS-Normal |
6.087800E-01 |
| Tall-VS-Follicular |
8.886100E-02 |
| Tall-VS-Other |
9.336800E-01 |
| Tall-VS-Normal |
2.006400E-02 |
| Follicular-VS-Other |
6.152800E-01 |
| Follicular-VS-Normal |
9.770400E-01 |
| Other-VS-Normal |
6.286400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.248000E-01 |
| Normal-vs-N1 |
5.8961000000024E-05 |
| N0-vs-N1 |
6.37829999999839E-05 |
|
|
